SYNTHETIC INJECTABLE BONE SUBSTITUTE

Brand	Owner	Address	Description
MAXILLENT	MAXILLENT LTD.	85 Medinat Hayehudim Street P.O. Box 12593 Herzlia 46766 Israel	Synthetic injectable bone substitute for use with dental implants;Dental implants;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Injectable compositions containing gabapentin and processes for preparing sterile injectable compositions containing gabapentin are discussed. The process includes subjecting the compositions to heat. Heating results in increased production of gabapentin lactam, which has previously been shown to be toxic. Surprisingly, heated injectable compositions containing gabapentin are found to be non-toxic when administered intrathecally. Thus, heating for the purposes of sterilization or to assure sterility provides a viable option in the production of injectable compositions containing gabapentin.